Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVidendum Plc Regulatory News (VID)

Share Price Information for Videndum Plc (VID)

Share Price is delayed by 15 minutes
Get Live Data
377.50    -14.50 (-3.70%)
Bid:
375.00
Ask:
380.00
Spread: 5.00 (1.333%)
Market Cap: £157.95m
VID Live PriceLast checked at - London Stock Exchange

Intraday Videndum Plc Share Chart

Director/PDMR Shareholding

4 Apr 2023 12:00

RNS Number : 3234V
Videndum PLC
04 April 2023
Β 

Β 

4 April 2023

Β 

Β 

VIDENDUM PLC

Β 

Notification of Transactions of Directors and Persons Discharging Managerial Responsibility (PDMRs)

Β 

Deferred Bonus Plan - Vesting of 2020 Awards

Β 

Videndum plc ("the Company") announces that the following transactions were undertaken by Directors and PDMRs in the ordinary shares of the Company on 3 April 2023 in connection with the maturity of the 2020 Deferred Bonus Plan ("DBP"). In summary, for the 2020 DBP, each Director or PDMR deferred a proportion of their 2019 annual cash bonus into the DBP. The deferred bonus was used to purchase shares in the Company at a price of Β£5.81 per share ("DBP award shares") that were held in the Employee Trust for a three-year deferral period. No performance conditions are attached to the DBP award shares and dividends paid during the deferral period on the DBP award shares have been automatically reinvested in additional dividend shares. There are no matching award shares that can be earned on the DBP award shares.

Β 

Stephen Bird, Group Chief Executive

Β 

Transaction

Date of transfer

Total shares vested including dividend shares

Number of shares retained

Β 

Price per share at which associated dividend shares were acquired

Transfer of DBP award shares (including associated dividend shares)

3 April 2023

6,023 (of which 5,676 were DBP award shares)

6,023

Β£8.89

Β 

Β 

Marco Pezzana, PDMR

Β 

Transaction

Date of transfer

Total shares vested including dividend shares

Number of shares retained

Β 

Price per share at which associated dividend shares were acquired

Transfer of DBP award shares (including associated dividend shares)

3 April 2023

2,625 (of which 2,474 were DBP award shares)

2,625

Β£8.89

Β 

Β 

Β 

Jon Bolton, PDMR

Β 

Transaction

Date of transfer

Total shares vested including dividend shares

Number of shares retained

Β 

Price per share at which associated dividend shares were acquired

Transfer of DBP award shares (including associated dividend shares)

3 April 2023

755 (of which 712 were DBP award shares)

755

Β£8.89

Β 

Β 

Deferred Bonus Plan (DBP) - 2023 Awards

Β 

The Company further announces that awards under the Deferred Bonus Plan ("DBP") have been made on 3 April 2023 following purchases of ordinary shares of 20 pence each by the following Executive Directors and PDMRs following the deferral of a proportion of the 2022 bonus. The shares were purchased at an average price of Β£8.763941 and will be held by Apex Fund Services in a nominee capacity on behalf of the Executive Directors and PDMRs.

Β 

The shares purchased will be held for three years until vesting under the normal operation of the DBP.

Β 

There are no performance conditions or matching shares associated with the DBP.

Β 

Name

Position

Number of shares purchased for 2023 DBP Award

Percentage of 2022 annual bonus deferred

Current shareholding following 2020 DBP vesting and 2023 DBP award*

Β 

% of 2023 salary held for Executive Directors***

Stephen Bird

Group Chief Executive

9,093

50%

217,083 (22,745)*

376%

Andrea Rigamonti

Group Chief Financial OfficerΒ 

317

50% (since appointment as a Director)

6,206 (317)*

18%

Marco Pezzana

PDMR

3,365

30%

104,539 (9,077)*

-

Nicola Dal Toso

PDMR

4,599

30%

14,831 (8,831)*

-

Marco Vidali

PDMR

2,408

30%

9,541 (2,408)*

-

Jon Bolton

PDMR

1,336

20%

34,797 (3,218)*

-

Β 

Β 

* The number in brackets refers to the number of ordinary shares purchased in the market with funds provided by the Executive Director or PDMR and which are held by Apex Fund Services, the Trustee used to hold shares in respect of awards made under Videndum plc 2014 Deferred Bonus Plan.

Β 

** Stephen Bird's current shareholding also reflects 2,000 shares held through a connected person.

Β 

*** Based on closing mid-market share price on 31 March 2023.

Β 

As a consequence of the above transactions, each Executive Director and PDMR has increased their shareholding in the Company.

Β 

Enquiries:

Β 

Jon Bolton

Group Company Secretary

Β 

020 8332 4600

Β 

Β 

A snapshot of Videndum plc

Β 

Videndum is a leading global provider of premium branded hardware products and software solutions to the growing content creation market. We are organised in three Divisions: Videndum Media Solutions, Videndum Production Solutions and Videndum Creative Solutions.

Β 

Videndum's customers include broadcasters, film studios, production and rental companies, photographers, independent content creators, gamers, professional musicians and enterprises. Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, smartphone accessories, robotic camera systems, prompters, LED lighting, mobile power, carrying solutions, backgrounds, motion control, audio capture, and noise reduction equipment.

Β 

We employ around 1,900 people across the world in 11 different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.

Β 

More information can be found at:Β https://videndum.com/

Β 

LEI number:Β 2138007H5DQ4X8YOCF14

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUPUQCCUPWURC
Date   Source Headline
31st Mar 20257:00 amRNSMarch Covenant Test Waived
19th Mar 20257:00 amRNSDirectorate Change
11th Mar 20253:45 pmRNSHolding(s) in Company
5th Mar 20254:00 pmRNSHolding(s) in Company
21st Feb 20257:00 amRNSTrading Update
8th Jan 20257:00 amRNSHolding(s) in Company
7th Jan 202510:00 amRNSDirector/PDMR Shareholding
19th Dec 20241:38 pmRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSPre-Close Trading Update
11th Dec 20247:00 amRNSPre-Close Trading Update - Change of Date
22nd Nov 20242:15 pmRNSHolding(s) in Company
22nd Nov 20241:00 pmRNSNotice of Pre-Close Trading Update
20th Nov 20247:00 amRNSBlock listing Interim Review
6th Nov 20248:50 amRNSTransaction in Own Shares and cancellation
6th Nov 20248:34 amRNSShare buyback and cancellation programme
1st Nov 20249:58 amRNSTotal Voting Rights
28th Oct 20247:00 amRNSDirectorate Changes
10th Oct 20243:45 pmRNSHolding(s) in Company
8th Oct 20243:05 pmRNSHolding(s) in Company
4th Oct 20247:00 amRNSHolding(s) in Company
1st Oct 20243:40 pmRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSHolding(s) in Company
27th Sep 20243:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNS2024 Interim Results
2nd Sep 20249:23 amRNSTotal Voting Rights
1st Aug 202412:30 pmRNSTotal Voting Rights
11th Jul 20247:00 amRNS2024 Half Year Post-close Statement
19th Jun 202411:05 amRNSResult of AGM
19th Jun 20247:00 amRNSNon-Executive Director appointment
13th Jun 202411:00 amRNSDirector/PDMR Shareholding
20th May 202411:45 amRNSBlock listing Interim Review
16th May 20245:00 pmRNSDirector/PDMR Shareholding
10th May 202410:26 amRNSChange in Director's Details
8th May 20244:15 pmRNSAnnual Report & Accounts and Notice of 2024 AGM
7th May 202411:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSDirectorate Change
23rd Apr 20247:10 amRNSDirectorate Change
23rd Apr 20247:00 amRNS2023 Full Year Results
27th Mar 20242:03 pmRNSUpdate on timing of 2023 Full Year Results
13th Mar 20242:15 pmRNSDelay to 2023 Full Year Results Date
7th Mar 20241:30 pmRNSHolding(s) in Company
23rd Feb 20244:38 pmRNSHolding(s) in Company
9th Feb 202410:46 amRNSHolding(s) in Company
26th Jan 202411:38 amRNSHolding(s) in Company
11th Jan 20244:47 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSTotal Voting Rights
12th Dec 20232:01 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSHolding(s) in Company
11th Dec 202312:27 pmRNSHolding(s) in Company
11th Dec 20238:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.